Alphaxalone inhibits growth, migration and invasion of rat C6 malignant glioma cells

Steroids

Volumn 78, Issue 10, 2013, Pages 1041-1045

  Sun, Huawei ^a   Zheng, Xiaoke ^a   Zhou, Yuehan ^b   Zhu, Wenbo ^c   Ou, Yanqiu ^d   Shu, Minfeng ^c   Gao, Xiuren ^a   Leng, Tiandong ^c   Qiu, Pengxin ^c   Yan, Guangmei ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUILIN MEDICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Alphaxalone; Invasion; Malignant glioma; Proliferation

Indexed keywords

ALFAXALONE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; GLIOMA; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; RAT; TUMOR GROWTH; TUMOR INVASION; XENOGRAFT;

RATTUS;

ALPHAXALONE; INVASION; MALIGNANT GLIOMA; PROLIFERATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GLIOMA; HUMANS; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; PREGNANEDIONES; RATS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84885000077     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2013.06.008     Document Type: Article

References (15)

1. DeAngelis LM. Brain tumors. N Engl J Med 2001;344:114-23.
2. Giese A, Rief MD, Loo MA, Berens ME. Determinants of human astrocytoma migration. Cancer Res 1994;54:3897-904.
3. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003;21:1624-36.
4. Harrison NL, Simmonds MA. Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res 1984;323:287-92.
5. Wu FS, Gibbs TT, Farb DH. Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol Pharmacol 1991;40:333-6.
6. Petitti DB, Sidney S, Quesenberry Jr CP, Bernstein A. Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy. Stroke 1998;29:23-8.
7. Morissette M, Al SS, Callier S, Di PT. Estrogen and SERM neuroprotection in animal models of Parkinson's disease. Mol Cell Endocrinol 2008;290:60-9.
8. Aly HF, Metwally FM, Ahmed HH. Neuroprotective effects of dehydroepiandrosterone (DHEA) in rat model of Alzheimer's disease. Acta Biochim Pol 2011;58:513-20.
9. Harrison NL, Vicini S, Barker JL. A steroid anesthetic prolongs inhibitory postsynaptic currents in cultured rat hippocampal neurons. J Neurosci 1987;7:604-9.
10. Leng T, Zhang J, Xie J, Zhou S, Huang Y, Zhou Y, et al. Synthesis and anti-glioma activity of 25(R)-spirostan-3beta,5alpha,6beta,19-tetrol. Steroids 2010;75:224-9.
11. Xie J, Li Y, Huang Y, Qiu P, Shu M, Zhu W, et al. Anesthetic pentobarbital inhibits proliferation and migration of malignant glioma cells. Cancer Lett 2009;282:35-42.
12. Shu M, Zheng X, Wu S, Lu H, Leng T, Zhu W, et al. Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells. Mol Cancer 2011;10:59.
13. Nakada M, Nakada S, Demuth T, Tran NL, Hoelzinger DB, Berens ME. Molecular targets of glioma invasion. Cell Mol Life Sci 2007;64:458-78.
14. Gies A, Westphal M. Glioma invasion in the central nervous system. Neurosurgery 1996;39:235-50.
15. Hales TG, Tynadale RF. Few cell lines with GABAA mRNAs have functional receptors. J Neurosci 1994;14:5429-36.